1 / 12

Small Lymphocytic Lymphoma

The Small lymphocytic lymphoma market report provides current treatment practices, emerging drugs, Small lymphocytic lymphoma market share of the individual therapies, current and forecasted Small lymphocytic lymphoma market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Small lymphocytic lymphoma treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.<br><br>

yashb
Download Presentation

Small Lymphocytic Lymphoma

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Small Lymphocytic Lymphoma Presented by- DelveInsight Business Research

  2. What is Small Lymphocytic Lymphoma Market? Small-cell lymphocytic lymphoma (SLL) is a subtype of NHL (indolent lymphomas) which affects infection-fighting white blood cells called B-cells. These B-cells may be present in lymph nodes and lymphoid tissue such as the spleen and the tonsils. Non-Hodgkin lymphoma (NHL) is a cancer that starts in white blood cells called lymphocytes, which are part of the body’s immune system. NHL accounts for 4% of all cancers in the United States and is divided into more than 30 types, classified based on the type of lymphocyte involved: B lymphocytes (B cells) or T lymphocytes (T cells). Non-Hodgkin lymphoma is further classified by other factors, including whether it is aggressive (fast-growing) or indolent (slow-growing).

  3. SLL is one type of NHL, which is very similar to another NHL type: chronic lymphocytic leukemia (CLL). The two cancers are fundamentally the same disease, and they are treated in the same way. The only difference is each cancer (SLL and CLL) is located in a different part of the body. SLL/CLL tends to grow gradually. About one-third of all people with SLL live for years without having symptoms. The foremost symptom of SLL/CLL is painless swelling in the neck, armpit, and groin. It is caused by cancer cells building up inside the lymph nodes. Other symptoms include: Fatigue, unexpected weight loss, Fever, night sweats, Loss of appetite etc. Read More @ Small Lymphocytic Lymphoma Market

  4. The exact causes of SLL/CLL are still unknown. It has been stated that SLL is not infectious and cannot be passed on to other people. Few factors, however increase the risk for SLL, which includes working on a farm or as a hair stylist or any other disease that weak immune system. CLL can be diagnosed on a blood test. SLL is usually diagnosed by taking a sample of cells from a swollen lymph node to look at under a microscope. This is called a lymph node biopsy. Depending upon patient’s condition, treatments for SLL/CLL may include the following: Chemotherapy, Targeted therapy, Steroids, Stem cell transplants and Radiotherapy. View Small Lymphocytic Lymphoma Market Report

  5. How Many Regions Are Covered? The US EU5 (Germany, France, Italy, Spain, and the United Kingdom) Japan

  6. When someone suffers from CLL/SLL the overall outlook depends on the stage of the cancer and other variables. Because of the way that blood and bone marrow are involved in CLL, the staging systems for CLL are different from those used for other types of NHL, including SLL. Patients with CLL are staged using either the Rai staging system (mostly used in US) or the Binet classification system (more widely in Europe). CLL/SLL are slow growing cancer which are not curable however, it is manageable with treatment. One of the major unmet need is that CLL/SLL often comes back after it is treated. Most people will need to go through a few rounds of treatment to keep their cancer under control. Treatment aims to reduce the symptoms and keep the CLL/SLL under control for as long as possible with as few side effects as possible

  7. KOL- Views To keep up with the market trends, we take KOLs and SME’s opinion working in Small Lymphocytic Lymphoma domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Small Lymphocytic Lymphomamarket trend. This will support the clients in making informed business decisions by identifying the overall scenario of the market and the unmet needs.

  8. What is the Small Lymphocytic Lymphoma Market Report Scope? • The report covers the descriptive overview of Small Lymphocytic Lymphoma, explaining its applications, advantages, and limitations, etc. • Additionally, an all-inclusive account of the currently available Small Lymphocytic Lymphoma is provided, which will have an impact on the future market of Small Lymphocytic Lymphoma. • A detailed review of Small Lymphocytic Lymphoma market; historical and forecasted market size is included in the report, covering devices outreach in the 7MM. • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Small Lymphocytic Lymphoma market.

  9. What are the Small Lymphocytic Lymphoma Market Report Highlights? • The report covers descriptive overview of the Small Lymphocytic Lymphoma, explaining its applications, working mechanism, etc. • The report provides an insight into the patient population eligible for Implantation of Cardiac monitors in the 7 MM, covering the US, EU5 (Germany, Spain, France, Italy, UK) & Japan. • The report is a comprehensive account of marketed devices present in the Small Lymphocytic Lymphomamarket. • The report also reviews the detailed global historical and forecasted Small Lymphocytic Lymphomamarket including assessing the outreach in 7 MM. • The report helps in developing business strategies by understanding trends shaping and driving the global Small Lymphocytic Lymphoma market.

  10. info@delveinsight.com ybhardwaj@delveinsight.com +91-9650213330 Do You Have Any Question or Query? Please keep this slide for attribution

  11. Thanks!

More Related